Unnamed: 0,title,date,stock,sentiment
12510.0,"ACADIA Pharmaceuticals Appoints Mark Schneyer as Senior Vice President, Business Development and Chief Business Officer",2020-05-28 09:04:00-04:00,ACAD,neutral
12511.0,"Oppenheimer Maintains Perform on ACADIA Pharmaceuticals, Raises Price Target to $53",2020-05-27 08:27:00-04:00,ACAD,neutral
12512.0,ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder,2020-05-26 09:00:00-04:00,ACAD,negative
12513.0,ACADIA Pharma Will Present Pimavanserin Data At American Society Of Clinical Psychopharmacology Meeting May 29-30,2020-05-21 09:04:00-04:00,ACAD,neutral
12514.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,ACAD,negative
12515.0,"JP Morgan Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $55",2020-05-08 12:00:00-04:00,ACAD,neutral
12516.0,10 Biggest Price Target Changes For Friday,2020-05-08 08:40:00-04:00,ACAD,neutral
12517.0,"ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.UPDATE: Shares have since reversed, now higher.",2020-05-08 08:12:00-04:00,ACAD,positive
12518.0,38 Stocks Moving in Friday's Pre-Market Session,2020-05-08 07:36:00-04:00,ACAD,neutral
12519.0,"Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Raises Price Target to $63",2020-05-08 07:05:00-04:00,ACAD,negative
12520.0,16 Stocks Moving In Thursday's After-Hours Session,2020-05-07 18:55:00-04:00,ACAD,neutral
12521.0,ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.,2020-05-07 17:07:00-04:00,ACAD,neutral
12522.0,"ACADIA Pharmaceuticals Q1 EPS $(0.570) Misses $(0.480) Estimate, Sales $90.068M Miss $91.510M Estimate",2020-05-07 17:02:00-04:00,ACAD,negative
12523.0,ACADIA Pharmaceuticals And Vanderbilt University Announce Exclusive License Agreement And Research Collaboration,2020-05-07 16:50:00-04:00,ACAD,positive
12524.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ACAD,negative
12525.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ACAD,neutral
12526.0,"Benzinga's Top Upgrades, Downgrades For April 16, 2020",2020-04-16 09:34:00-04:00,ACAD,positive
12527.0,"Jefferies Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target to $60",2020-04-16 06:57:00-04:00,ACAD,neutral
12528.0,Acadia Realty Trust Withdraws FY20 Guidance,2020-03-31 17:07:00-04:00,ACAD,positive
12529.0,ACADIA Pharmaceuticals shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised the price target from $45 to $72.,2020-03-31 09:19:00-04:00,ACAD,positive
12530.0,"Goldman Sachs Upgrades ACADIA Pharmaceuticals to Buy, Raises Price Target to $72",2020-03-31 05:05:00-04:00,ACAD,neutral
12531.0,10 Small-To-Mid-Cap Biotech Ideas For When The Coronavirus Fades,2020-03-17 17:13:00-04:00,ACAD,neutral
12532.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,ACAD,negative
12533.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,ACAD,neutral
12534.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2020",2020-03-06 09:39:00-05:00,ACAD,positive
12535.0,"Citigroup Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces $69 Price Target",2020-03-06 04:54:00-05:00,ACAD,neutral
12536.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,ACAD,negative
12537.0,ACADIA Pharma Reports Rare Pediatric Disease Designation For Trofinetide For Treatment Of Rett Syndrome,2020-03-03 18:00:00-05:00,ACAD,neutral
12538.0,"JP Morgan Maintains Neutral on ACADIA Pharmaceuticals, Lowers Price Target to $33",2020-03-02 09:01:00-05:00,ACAD,positive
12539.0,Ansys shares are trading lower after the company issued Q1 EPS and sales guidance below estimates.,2020-02-27 11:18:00-05:00,ACAD,neutral
12540.0,"Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Raises Price Target to $75",2020-02-27 07:03:00-05:00,ACAD,negative
12541.0,21 Stocks Moving In Wednesday's After-Hours Session,2020-02-26 18:03:00-05:00,ACAD,neutral
12542.0,ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2020-02-26 17:02:00-05:00,ACAD,positive
12543.0,ACADIA Pharmaceuticals Sees FY20 NUPLAZID Net Sales Are Expected To Be Between $440M- $470M,2020-02-26 16:19:00-05:00,ACAD,neutral
12544.0,"ACADIA Pharmaceuticals Q4 EPS $(0.34) Beats $(0.36) Estimate, Sales $98.326M Beat $96.76M Estimate",2020-02-26 16:17:00-05:00,ACAD,neutral
12545.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",2020-02-26 09:36:00-05:00,ACAD,negative
12546.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,ACAD,neutral
12547.0,ACADIA Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2020-01-06 14:02:00-05:00,ACAD,positive
12548.0,A Perspective On Biopharma's Record M&A Run In 2019,2019-12-23 14:57:00-05:00,ACAD,neutral
12549.0,ACADIA Pharmaceuticals shares are trading lower. Not seeing any company-specific news to justify the price action.,2019-12-18 10:19:00-05:00,ACAD,neutral
12550.0,"Benzinga's Top Upgrades, Downgrades For December 16, 2019",2019-12-16 10:10:00-05:00,ACAD,positive
12551.0,"Guggenheim Securities Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces $60 Price Target",2019-12-16 08:07:00-05:00,ACAD,positive
12552.0,"ACADIA Pharmaceuticals shares are trading lower potentially after the company's CEO, Stephen Davis, sold $7.9 million worth of shares.",2019-12-09 11:54:00-05:00,ACAD,positive
12553.0,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",2019-12-06 07:39:00-05:00,ACAD,positive
12554.0,75 Biggest Movers From Yesterday,2019-12-06 05:36:00-05:00,ACAD,neutral
12555.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-12-05 12:07:00-05:00,ACAD,neutral
12556.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-05 10:16:00-05:00,ACAD,neutral
12557.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-05 07:55:00-05:00,ACAD,neutral
12558.0,ACADIA Pharmaceuticals shares are trading higher after the company reported the results from its pivotal phase 3 HARMONY trial of pimavanserin in patients with dementia-related psychosis met the primary endpoint and key secondary endpoint.,2019-12-05 07:32:00-05:00,ACAD,positive
12559.0,40 Stocks Moving in Thursday's Pre-Market Session,2019-12-05 07:30:00-05:00,ACAD,neutral
12560.0,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",2019-12-05 07:14:00-05:00,ACAD,positive
12561.0,"The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug",2019-12-04 07:06:00-05:00,ACAD,negative
12562.0,"The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More",2019-12-01 09:30:00-05:00,ACAD,neutral
12563.0,10 Biggest Price Target Changes For Tuesday,2019-11-26 09:46:00-05:00,ACAD,neutral
12564.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,ACAD,positive
12565.0,"Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Raises Price Target to $70",2019-11-26 07:51:00-05:00,ACAD,negative
12566.0,"ACADIA Pharmaceuticals shares are trading lower after the company announced results from the ADVANCE trial of Pimavanserin. In the study, pimavanserin did not separate from placebo on the key secondary endpoint.",2019-11-25 16:10:00-05:00,ACAD,neutral
12567.0,ACADIA Pharma Reports Top-Line Results From ADVANCE Trial Of Pimavanserin As Treatment For Negative Symptoms Of Schizophrenia; Will Initiate Second Pivotal Study In H1'20,2019-11-25 16:06:00-05:00,ACAD,negative
12568.0,"ACADIA Pharmaceuticals Announces Pimavanserin Demonstrated Statistically Significant Improvement In Primary Endpoint, Did Not Separate From Placebo On Key Secondary Endpoint",2019-11-25 16:05:00-05:00,ACAD,positive
12569.0,Stocks That Hit 52-Week Highs On Friday,2019-11-22 10:17:00-05:00,ACAD,neutral
12570.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,ACAD,positive
12571.0,ACADIA Pharmaceuticals Option Alert: Dec 20 $52 Calls at the Ask: 600 @ $1.47 vs 5 OI; Ref=$47.63,2019-11-21 15:12:00-05:00,ACAD,positive
12572.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,ACAD,neutral
12573.0,ACADIA Pharmaceuticals shares are trading higher. Not currently seeing any company-specific news.,2019-11-12 10:33:00-05:00,ACAD,positive
12574.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-12 10:11:00-05:00,ACAD,neutral
12575.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,ACAD,neutral
12576.0,ACADIA Pharmaceuticals shares are trading higher. Not yet seeing any company-specific news.,2019-11-11 11:32:00-05:00,ACAD,positive
12577.0,"JP Morgan Maintains Neutral on ACADIA Pharmaceuticals, Raises Price Target to $35",2019-11-07 07:56:00-05:00,ACAD,positive
12578.0,ACADIA Pharma Reports Initiation Of Phase 3 Study Of Trofinetide in Rett Syndrome,2019-10-30 17:13:00-04:00,ACAD,neutral
12579.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,ACAD,negative
12580.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,ACAD,neutral
12581.0,"Benzinga's Top Upgrades, Downgrades For October 24, 2019",2019-10-24 10:03:00-04:00,ACAD,positive
12582.0,"Oppenheimer Initiates Coverage On ACADIA Pharmaceuticals with Perform Rating, Announces $44 Price Target",2019-10-24 06:53:00-04:00,ACAD,neutral
12583.0,ACADIA Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-10-21 10:50:00-04:00,ACAD,positive
12584.0,ACADIA Pharmaceuticals Highlights Presentation Of Additional Positive Data From The Phase 2 CLARITY Study With Pimavanserin In Adjunctive Major Depressive Disorder At 2019 Psych Congress,2019-10-07 09:04:00-04:00,ACAD,positive
12585.0,ACADIA Pharmaceuticals Announces Late-Breaking Oral Presentation Of The Phase 3 HARMONY Study Of Pimavanserin In Dementia-Related Psychosis At The Clinical Trials on Alzheimer's Disease (CTAD) 2019 Meeting Dec 4th,2019-10-03 16:56:00-04:00,ACAD,positive
12586.0,"Benzinga's Top Upgrades, Downgrades For October 1, 2019",2019-10-01 09:46:00-04:00,ACAD,positive
12587.0,ACADIA Pharmaceuticals shares are trading higher after RBC Capital initiated coverage on the company's stock with an Outperform rating and a $60 price target.,2019-10-01 08:37:00-04:00,ACAD,positive
12588.0,"RBC Capital Initiates Coverage On ACADIA Pharmaceuticals with Outperform Rating, Announces $60 Price Target",2019-10-01 06:42:00-04:00,ACAD,neutral
12589.0,"Shares of several healthcare companies are trading lower, potentially on recent Democratic primary polls showing Senator Elizabeth Warren in the lead.",2019-09-26 12:43:00-04:00,ACAD,neutral
12590.0,ACADIA Pharmaceuticals Announces That The Journal of Clinical Psychiatry Publishes Positive Phase 2 CLARITY Results for Pimavanserin as Adjunctive Treatment for Patients with Major Depressive Disorder,2019-09-24 16:06:00-04:00,ACAD,positive
12591.0,Shares of many pharma/therapeutics stocks trading lower in sympathy with overall market weakness. Reports China is planning to cut prices for widely-used drugs may also be pressuring the sector today.,2019-09-24 14:01:00-04:00,ACAD,negative
12592.0,Acadia Pharmaceuticals shares are trading lower on seemingly no company-specific news. The negative price action can potentially be profit-taking after the company reported positive data on Pimavanserin.,2019-09-24 12:15:00-04:00,ACAD,negative
12593.0,"ACADIA Pharmaceuticals shares are trading higher after the company presented results of its Phase 2 study of Pimavanserin, which 'significantly improved depression symptoms for Parkinson's patients.' Cantor Fitzgerald maintained an Overweight rating.",2019-09-23 11:31:00-04:00,ACAD,negative
12594.0,"ACADIA Pharma Presents New Data on Pimavanserin, Says Patients Showed 'Significant Improvement' on the Primary Endpoint",2019-09-23 09:02:00-04:00,ACAD,positive
12595.0,10 Biggest Price Target Changes For Monday,2019-09-23 08:52:00-04:00,ACAD,neutral
12596.0,"Cantor Fitzgerald Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $56",2019-09-23 07:43:00-04:00,ACAD,negative
12597.0,"Notable Insider Buys In The Past Week: AbbVie, Kraft Heinz And More",2019-09-22 17:00:00-04:00,ACAD,neutral
12598.0,36 Stocks Moving In Wednesday's Mid-Day Session,2019-09-18 13:19:00-04:00,ACAD,neutral
12599.0,10 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-18 08:13:00-04:00,ACAD,neutral
12600.0,30 Stocks Moving in Wednesday's Pre-Market Session,2019-09-18 07:52:00-04:00,ACAD,neutral
12601.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,ACAD,neutral
12602.0,ACADIA Pharmaceuticals shares are trading lower after the company priced its common stock offering of 6.25 million shares at $40 per share.,2019-09-18 07:16:00-04:00,ACAD,positive
12603.0,"5 Stocks To Watch For September 18, 2019",2019-09-18 04:28:00-04:00,ACAD,neutral
12604.0,ACADIA Pharmaceuticals Prices 6.25M Share Public Offering of Common Stock @$40/Share,2019-09-18 04:23:00-04:00,ACAD,positive
12605.0,7 Stocks Moving In Tuesday's After-Hours Session,2019-09-17 16:35:00-04:00,ACAD,neutral
12606.0,ACADIA Pharma shares are trading lower after the company reported a $250 million common stock offering.,2019-09-17 16:17:00-04:00,ACAD,neutral
12607.0,ACADIA Pharma Reports $250M Common Stock Offering,2019-09-17 16:16:00-04:00,ACAD,neutral
12608.0,Shares of Acadia Healthcare Dropping on Negative Report Circulating via Twitter; Shares of Acadia Pharmaceuticals Fell on Confusion of Two Companies,2019-09-17 15:27:00-04:00,ACAD,negative
12609.0,"The Daily Biotech Pulse: Acceleron Shelves Muscular Dystrophy Drug Trial, Aclaris Aces Late-Stage Study",2019-09-17 07:23:00-04:00,ACAD,neutral
12610.0,﻿ACADIA Pharmaceuticals shares are trading higher on continued momentum after SVB Leerink upgraded the stock from Market Perform to Outperform and raised the price target from $21 to $50 per share.,2019-09-16 11:10:00-04:00,ACAD,positive
12611.0,ACADIA Pharmaceuticals shares are trading higher after SVB Leerink upgraded the stock from Market Perform to Outperform and raised the price target from $21 to $50 per share.,2019-09-13 11:18:00-04:00,ACAD,positive
12612.0,"Benzinga's Top Upgrades, Downgrades For September 13, 2019",2019-09-13 09:56:00-04:00,ACAD,positive
12613.0,10 Biggest Price Target Changes For Friday,2019-09-13 08:58:00-04:00,ACAD,neutral
12614.0,"SVB Leerink Upgrades ACADIA Pharmaceuticals to Outperform, Raises Price Target to $50",2019-09-13 08:11:00-04:00,ACAD,neutral
12615.0,ACADIA Pharmaceuticals shares are trading higher after analysts at Canaccord Genuity upgraded the company's stock from Hold to Buy.,2019-09-10 13:25:00-04:00,ACAD,positive
12616.0,'Pleasantly Surprised' Acadia Analysts See Blockbuster Potential For Pimavanserin In Dementia Psychosis,2019-09-10 13:20:00-04:00,ACAD,positive
12617.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, September 10, 2019",2019-09-10 11:48:00-04:00,ACAD,positive
12618.0,"Benzinga's Top Upgrades, Downgrades For September 10, 2019",2019-09-10 09:38:00-04:00,ACAD,positive
12619.0,"The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris",2019-09-10 07:36:00-04:00,ACAD,neutral
12620.0,Canaccord Genuity Upgrades ACADIA Pharmaceuticals to Buy,2019-09-10 06:37:00-04:00,ACAD,neutral
12621.0,84 Biggest Movers From Yesterday,2019-09-10 05:01:00-04:00,ACAD,neutral
12622.0,"Canaccord Genuity Raises ACADIA Pharmaceuticals To Buy, Raises Prices Target To $50",2019-09-09 16:53:00-04:00,ACAD,neutral
12623.0,Mid-Afternoon Market Update: NASADQ Down 0.5%; ACADIA Pharmaceuticals Shares Spike Higher,2019-09-09 14:58:00-04:00,ACAD,positive
12624.0,Acadia Stops Nuplazid Study Early After Drug Shows 'Statistically Superior Efficacy' In Dementia-Related Psychosis,2019-09-09 14:33:00-04:00,ACAD,positive
12625.0,Mid-Day Market Update: Crude Oil Up Over 2%; Neurotrope Shares Plunge,2019-09-09 12:27:00-04:00,ACAD,negative
12626.0,44 Stocks Moving In Monday's Mid-Day Session,2019-09-09 12:21:00-04:00,ACAD,neutral
12627.0,"A Look At Benzinga Pro's Most-Searched Tickers For September 9, 2019",2019-09-09 12:17:00-04:00,ACAD,neutral
12628.0,"Needham Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $60",2019-09-09 11:08:00-04:00,ACAD,neutral
12629.0,Hearing Needham Raised Price Target On ACADIA Pharma From $34 To $60,2019-09-09 10:58:00-04:00,ACAD,neutral
12630.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Monday., September 09, 2019",2019-09-09 10:32:00-04:00,ACAD,positive
12631.0,"Mid-Morning Market Update: Markets Mostly Higher; Alcoa To Consolidate Sales, Procurement And Commercial Operations",2019-09-09 10:15:00-04:00,ACAD,neutral
12632.0,27 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-09 08:42:00-04:00,ACAD,neutral
12633.0,ACADIA Pharmaceuticals shares are trading higher after the company announced its Harmony Phase 3 Trial met its primary endpoint.,2019-09-09 08:23:00-04:00,ACAD,positive
12634.0,30 Stocks Moving in Monday's Pre-Market Session,2019-09-09 07:57:00-04:00,ACAD,neutral
12635.0,ACADIA Pharma's Phase 3 HARMONY Trial Met its Primary Endpoint,2019-09-09 06:32:00-04:00,ACAD,positive
12636.0,"Stifel Nicolaus Maintains Hold on ACADIA Pharmaceuticals, Raises Price Target to $28",2019-09-03 08:06:00-04:00,ACAD,neutral
12637.0,"UPDATE: Cantor Fitzgerald Reiterates Overweight On Acadia Pharmaceuticals, Raises Target To $40 As Firm Notes 'enhanced conviction, due to recent diligence with multiple KOLs, for pimavanserin as treatment for negative symptoms in schizophrenia pts'",2019-08-27 13:06:00-04:00,ACAD,negative
12638.0,10 Biggest Price Target Changes For Tuesday,2019-08-27 09:06:00-04:00,ACAD,neutral
12639.0,"Cantor Fitzgerald Reiterates Overweight on ACADIA Pharmaceuticals, Raises Price Target to $40",2019-08-27 07:17:00-04:00,ACAD,negative
12640.0,A List Of Stocks Reaching New 52-Week Highs,2019-08-09 10:29:00-04:00,ACAD,positive
12641.0,100 Biggest Movers From Yesterday,2019-08-02 05:53:00-04:00,ACAD,neutral
12642.0,ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 sales guidance above analyst estimates.,2019-08-01 15:55:00-04:00,ACAD,positive
12643.0,72 Stocks Moving In Thursday's Mid-Day Session,2019-08-01 12:16:00-04:00,ACAD,neutral
12644.0,41 Stocks Moving In Thursday's Pre-Market Session,2019-08-01 08:05:00-04:00,ACAD,neutral
12645.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,ACAD,negative
12646.0,28 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-01 04:20:00-04:00,ACAD,neutral
12647.0,ACADIA Raises FY19 Sales Guidance From $290M-$300M To $320M-$330M Vs $292.81 Estimates,2019-07-31 16:44:00-04:00,ACAD,neutral
12648.0,ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 sales guidance above analyst estimates.,2019-07-31 16:44:00-04:00,ACAD,positive
12649.0,"ACADIA Pharmaceuticals Q2 EPS $(0.38) Beats $(0.45) Estimate, Sales $83.205M Beat $72.57M Estimate",2019-07-31 16:38:00-04:00,ACAD,neutral
12650.0,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",2019-07-31 07:06:00-04:00,ACAD,negative
12651.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,ACAD,neutral
12652.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,ACAD,negative
12653.0,60 Biggest Movers From Yesterday,2019-07-24 04:57:00-04:00,ACAD,neutral
12654.0,45 Stocks Moving In Tuesday's Mid-Day Session,2019-07-23 13:09:00-04:00,ACAD,neutral
12655.0,25 Stocks Moving In Tuesday's Pre-Market Session,2019-07-23 07:57:00-04:00,ACAD,neutral
12656.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,ACAD,negative
12657.0,ACADIA Pharmaceuticals shares are trading lower after the company reported its Phase 3 ENHANCE trial of Pimavanserin did not achieve statistical significance on its primary endpoint.,2019-07-23 06:23:00-04:00,ACAD,negative
12658.0,"ACADIA Pharma Reports Top-Line Results From Phase 3 ENHANCE Trial Of Pimavanserin As Adjunctive Treatment For Patients With Schizophrenia: 'did not achieve statistical significance on the primary endpoint, but showed a consistent trend in improvement...'",2019-07-22 16:06:00-04:00,ACAD,negative
12659.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,2019-07-11 10:36:00-04:00,ACAD,negative
12660.0,ACADIA Pharmaceuticals Option Alert: Jul 19 $30 Calls Sweep (22) near the Ask: 500 @ $0.401 vs 151 OI; Earnings 8/7 After Close [est] Ref=$26.89,2019-07-01 14:50:00-04:00,ACAD,positive
12661.0,Many US-traded stocks are trading higher as new economic signals have raised the potential for a Federal Reserve rate cut.,2019-06-07 15:33:00-04:00,ACAD,negative
12662.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,ACAD,positive
12663.0,ACADIA Pharmaceuticals Option Alert: Jan 17 $28 Calls Sweep (2) near the Ask: 990 @ $3.451 vs 0 OI; Ref=$24.72,2019-05-20 13:17:00-04:00,ACAD,positive
12664.0,ACADIA Pharmaceuticals to Present Phase 2 CLARITY Results for Pimavanserin as an Adjunctive Treatment in MDD at 2019 American Psychiatric Association Annual Meeting,2019-05-18 19:58:00-04:00,ACAD,positive
12665.0,78 Biggest Movers From Yesterday,2019-05-03 05:08:00-04:00,ACAD,neutral
12666.0,54 Stocks Moving In Thursday's Mid-Day Session,2019-05-02 12:09:00-04:00,ACAD,neutral
12667.0,ACADIA Pharmaceuticals shares are trading higher after the company reported better-than-expected Q1 sales results and raised 2019 sales guidance.,2019-05-02 09:57:00-04:00,ACAD,positive
12668.0,"ACADIA Pharmaceuticals Q1 EPS $(0.59) Misses $(0.52) Estimate, Sales $62.959M Beat $60.69M Estimate",2019-05-01 17:42:00-04:00,ACAD,negative
12669.0,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",2019-05-01 07:39:00-04:00,ACAD,neutral
12670.0,ACADIA Pharma Reports Initiation Of Phase 3 CLARITY Program With Pimavanserin As Adjunctive Treatment for Major Depressive Disorder,2019-04-25 09:09:00-04:00,ACAD,negative
12671.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,ACAD,positive
12672.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,ACAD,negative
12673.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,ACAD,negative
12674.0,'A safety watchdog argues the FDA should reconsider approval of a Parkinson's psychosis drug' -STAT News,2019-04-02 16:00:00-04:00,ACAD,positive
12675.0,"ACADIA Pharmaceuticals To Present At The 18th Annual Needham Healthcare Conference On April 9, 2019",2019-04-02 09:04:00-04:00,ACAD,neutral
12676.0,ACADIA Pharma Promotes Elena Ridloff CFO,2019-04-01 09:03:00-04:00,ACAD,positive
12677.0,"The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO",2019-03-28 07:54:00-04:00,ACAD,neutral
12678.0,ACADIA Pharma Reports Statistically Significant Improvement Indicates Trofinetide's Potential for Treating Rett Syndrome,2019-03-27 16:12:00-04:00,ACAD,positive
12679.0,These Are Some Of The Best-Performing Leveraged ETFs Of The Year,2019-03-25 13:37:00-04:00,ACAD,neutral
12680.0,"Acadia Pharmaceuticals Says On March 5, Co Submitted Update to Data Available Through Centers For Medicare And Medicaid Services Open Payments Database to Reclassify Certain Categorization Information Regarding General Payments Provided to Physicians",2019-03-06 06:12:00-05:00,ACAD,positive
12681.0,"ACADIA Pharmaceuticals Inc Q4 EPS $(0.50) Beats $(0.55) Estimate, Sales $59.571M Beat $59.46M Estimate",2019-02-26 17:17:00-05:00,ACAD,neutral
12682.0,ACADIA Pharmaceuticals Sees FY19 NUPLAZID Sales $275M-$300M vs $297.15M Est.,2019-02-26 16:17:00-05:00,ACAD,neutral
12683.0,"ACADIA Pharmaceuticals Inc Q4 EPS $(0.50) Beats $(0.55) Estimate, Sales $59.57M Beat $59.46M Estimate",2019-02-26 16:15:00-05:00,ACAD,neutral
12684.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,ACAD,positive
12685.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,ACAD,neutral
12686.0,ACADIA Pharmaceuticals Option Alert: Mar 15 $23 Calls Sweep (9) near the Ask: 500 @ $1.6 vs 303 OI; Earnings 2/26 After Close [est] Ref=$20.53,2019-01-10 12:53:00-05:00,ACAD,positive
12687.0,"Canaccord Genuity Initiates Coverage On ACADIA Pharmaceuticals with Hold Rating, Announces $23 Price Target",2018-12-10 10:24:00-05:00,ACAD,neutral
12688.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Nov. 29, 2018",2018-11-29 11:02:00-05:00,ACAD,positive
12689.0,40 Biggest Movers From Yesterday,2018-11-29 05:33:00-05:00,ACAD,neutral
12690.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-11-28 12:19:00-05:00,ACAD,neutral
12691.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Nov. 28, 2018",2018-11-28 11:51:00-05:00,ACAD,positive
12692.0,ACADIA Pharma shares are trading higher after rumors surfaced that Baker Brothers have acquired a stake in the company.,2018-11-28 09:24:00-05:00,ACAD,positive
12693.0,48 Biggest Movers From Yesterday,2018-11-28 05:00:00-05:00,ACAD,neutral
12694.0,Acadia Pharmaceuticals Says Public Offering Of 16.2M Common Shares Priced At $17.00/Share,2018-11-27 21:22:00-05:00,ACAD,positive
12695.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-11-27 12:25:00-05:00,ACAD,neutral
12696.0,ACADIA Pharmaceuticals shares are trading down 9.9% after the company announced $200M common stock offering.,2018-11-27 12:19:00-05:00,ACAD,positive
12697.0,32 Stocks Moving In Tuesday's Pre-Market Session,2018-11-27 08:00:00-05:00,ACAD,neutral
12698.0,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",2018-11-27 07:32:00-05:00,ACAD,negative
12699.0,"7 Stocks To Watch For November 27, 2018",2018-11-27 05:33:00-05:00,ACAD,neutral
12700.0,ACADIA Pharmaceuticals shares are down 7.4% after hours following announcement of $200 million common stock offering.,2018-11-26 17:31:00-05:00,ACAD,positive
12701.0,5 Stocks Moving In Monday's After-Hours Session,2018-11-26 17:10:00-05:00,ACAD,neutral
12702.0,ACADIA Pharma Reports $200M Common Stock Offering,2018-11-26 16:08:00-05:00,ACAD,neutral
12703.0,"UBS Initiates Coverage On ACADIA Pharmaceuticals with Neutral Rating, Announces $39 Price Target",2018-11-16 09:07:00-05:00,ACAD,neutral
12704.0,"Leerink Swann Initiates Coverage On ACADIA Pharmaceuticals with Market Perform Rating, Announces $21 Price Target",2018-11-15 09:15:00-05:00,ACAD,neutral
12705.0,"Leerink Swann Initiates Coverage On ACADIA Pharmaceuticals with Market Perform Rating, Announces $21 Price Target",2018-11-13 08:50:00-05:00,ACAD,neutral
12706.0,ACADIA Pharma Sees FY18 NUPLAZID Sales $220M-$225M,2018-11-06 16:39:00-05:00,ACAD,neutral
12707.0,"ACADIA Pharmaceuticals Inc. Q3 EPS $(0.50) Beats $(0.58) Estimate, Sales $58.305M Beat $56.07M Estimate",2018-11-06 16:37:00-05:00,ACAD,neutral
12708.0,38 Stocks Moving In Wednesday's Pre-Market Session,2018-10-31 08:20:00-04:00,ACAD,neutral
12709.0,'Acadia Pharma conjures black magic to spin a failed depression drug trial' -STAT News' Adam Feuerstin,2018-10-31 07:52:00-04:00,ACAD,negative
12710.0,ACADIA Pharmaceuticals Reports Phase 2 CLARITY Trial Of Pimavanserin In Major Depressive Disorder Patients Met Primary Endpoint,2018-10-31 06:44:00-04:00,ACAD,negative
12711.0,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",2018-10-30 08:00:00-04:00,ACAD,neutral
12712.0,"ACADIA Pharmaceuticals Announces EVP And CFO Todd Young To Leave Co., Elena Ridloff To Serve As Interim CFO",2018-10-29 16:36:00-04:00,ACAD,negative
12713.0,26 Stocks Moving In Tuesday's Pre-Market Session,2018-10-09 08:19:00-04:00,ACAD,neutral
12714.0,"Acadia's FDA Boost Is Just The Beginning, Piper Jaffray Says In Upgrade",2018-09-21 11:21:00-04:00,ACAD,positive
12715.0,10 Biggest Price Target Changes For Friday,2018-09-21 09:51:00-04:00,ACAD,neutral
12716.0,"Benzinga's Top Upgrades, Downgrades For September 21, 2018",2018-09-21 09:20:00-04:00,ACAD,positive
12717.0,"PiperJaffray Upgrades ACADIA Pharmaceuticals to Overweight, Raises Price Target to $25",2018-09-21 07:01:00-04:00,ACAD,negative
12718.0,56 Biggest Movers From Yesterday,2018-09-21 04:48:00-04:00,ACAD,neutral
12719.0,"Cowen On ACADIA Pharma Following FDA's Nuplazid Public Statement: 'we do think the public statement will go a long way in allaying patient safety concerns, and very likely boost Nuplazid back to growth soon'",2018-09-20 14:56:00-04:00,ACAD,positive
12720.0,ACADIA Pharmaceuticals shares up 9.5% to $16.53; FDA posted analysis indicating no new or unexpected safety risks associated with nuplazid for hallucinations and delusions of Parkinson's disease.,2018-09-20 12:28:00-04:00,ACAD,positive
12721.0,ACADIA Shares Spiking On An FDA Post Titled 'FDA analysis finds no new or unexpected safety risks associated with Nuplazid' For Hallucinations And Delusions Of Parkinson's,2018-09-20 12:25:00-04:00,ACAD,positive
12722.0,ACADIA Pharmaceuticals Shares Spike To High Of $17.33/Shares Up ~14.50% On The Day,2018-09-20 12:24:00-04:00,ACAD,positive
12723.0,"Benzinga's Top Upgrades, Downgrades For August 23, 2018",2018-08-23 09:21:00-04:00,ACAD,positive
12724.0,"Jim Cramer Weighs In on Acadia, Dropbox, Ford And More",2018-08-23 07:46:00-04:00,ACAD,neutral
12725.0,"Cantor Fitzgerald Initiates Coverage On ACADIA Pharmaceuticals with Overweight Rating, Announces $25 Price Target",2018-08-23 07:08:00-04:00,ACAD,negative
12726.0,ACADIA Pharmaceuticals shares are up 10.9% on no news today; The company on Wednesday reported a Q2 earnings miss and cut 2018 sales guidance.,2018-08-10 10:58:00-04:00,ACAD,negative
12727.0,"Stocks Which Set New 52-Week Low Yesterday, August 9th",2018-08-10 10:05:00-04:00,ACAD,negative
12728.0,68 Stocks Moving In Thursday's Mid-Day Session,2018-08-09 12:41:00-04:00,ACAD,neutral
12729.0,ACADIA Biopharmaceuticals shares are trading 8.3% higher to $15.18 on high volume despite weak quarterly earnings report.,2018-08-09 10:27:00-04:00,ACAD,positive
12730.0,10 Biggest Price Target Changes For Thursday,2018-08-09 09:47:00-04:00,ACAD,neutral
12731.0,40 Stocks Moving In Thursday's Pre-Market Session,2018-08-09 08:09:00-04:00,ACAD,neutral
12732.0,"JMP Securities Maintains Market Outperform on ACADIA Pharmaceuticals, Lowers Price Target to $27",2018-08-09 07:42:00-04:00,ACAD,positive
12733.0,"ACADIA Cuts NUPLAZID FY18 Sales Guidance From $225-$270M To $210-$225M, Co. Sees Q3 NUPLAZID Sales Of $52-$59M",2018-08-08 16:06:00-04:00,ACAD,negative
12734.0,"ACADIA Pharmaceuticals Q2 EPS $(0.51) Misses $(0.45) Estimate, Sales $57.063M Miss $58.96M Estimate",2018-08-08 16:05:00-04:00,ACAD,negative
12735.0,Q2 Earnings Preview For ACADIA Pharmaceuticals,2018-08-08 10:10:00-04:00,ACAD,neutral
12736.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,ACAD,positive
12737.0,"Stocks Which Set New 52-Week Low Yesterday, August 6th",2018-08-07 11:28:00-04:00,ACAD,negative
12738.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,ACAD,negative
12739.0,"Stifel Nicolaus Initiates Coverage On ACADIA Pharmaceuticals with Hold Rating, Announces $17 Price Target",2018-08-07 07:48:00-04:00,ACAD,neutral
12740.0,52 Biggest Movers From Yesterday,2018-08-07 05:19:00-04:00,ACAD,neutral
12741.0,ACADIA Pharma Announces Exclusive License Agreement With Neuren Pharma For North American Development and Commercialization Of Trofinetide in Rett Syndrome; Co. Will Pay Neuren $10M Upfront Plus $455M In Potential Milestone and Royalty Payments,2018-08-06 17:17:00-04:00,ACAD,positive
12742.0,44 Stocks Moving In Monday's Mid-Day Session,2018-08-06 12:39:00-04:00,ACAD,neutral
12743.0,"Benzinga's Top Upgrades, Downgrades For August 6, 2018",2018-08-06 09:13:00-04:00,ACAD,positive
12744.0,"PiperJaffray Downgrades ACADIA Pharmaceuticals to Neutral, Announces $19 Price Target",2018-08-06 08:52:00-04:00,ACAD,neutral
12745.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-07-11 08:05:00-04:00,ACAD,neutral
12746.0,30 Biggest Movers From Yesterday,2018-07-10 05:02:00-04:00,ACAD,neutral
12747.0,"SIRF Out With New Negative Report On Acadia Titled, 'Acadia Pharmaceuticals: This Is Not a Pharmaceuticals Company'",2018-07-09 10:06:00-04:00,ACAD,negative
12748.0,PreMarket Prep Recap For July 5: Trading The Range In The S&P 500; Sean Udall Joins The Show,2018-07-05 09:54:00-04:00,ACAD,neutral
12749.0,"ACADIA Pharma Reports FDA Approval Of New Capsule Dose Fomulation For New Tablet Strength Of NUPLAZID For Treatment Of Hallucinations, Delusions Associated With Parkinson's",2018-06-29 07:33:00-04:00,ACAD,positive
12750.0,ACADIA Pharmaceuticals Option Alert: Sep 21 $20 Calls at the Ask: 10000 @ $1.15 vs 692 OI; Earnings 8/7 After Close [est] Ref=$15.8,2018-06-14 12:14:00-04:00,ACAD,positive
12751.0,38 Biggest Movers From Yesterday,2018-06-14 04:17:00-04:00,ACAD,neutral
12752.0,Acadia Pharma Option Alert: Jun 15 $17 Puts Sweep (2) near the Ask: 1065 @ $0.85 vs 7167 OI; Ref=$17.3705,2018-06-04 13:32:00-04:00,ACAD,positive
12753.0,24 Stocks Moving In Friday's Pre-Market Session,2018-05-18 08:04:00-04:00,ACAD,neutral
12754.0,"Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down",2018-05-04 08:16:00-04:00,ACAD,neutral
12755.0,ACADIA Pharmaceuticals Reaffirms FY2018 Sales $255.0M-270.0M vs $263.40M Est,2018-05-04 07:37:00-04:00,ACAD,neutral
12756.0,"ACADIA Pharmaceuticals Q1 EPS $(0.44) Beats $(0.56) Estimate, Sales $48.868M Beat $47.06M Estimate",2018-05-04 07:36:00-04:00,ACAD,neutral
12757.0,ACADIA Pharmaceuticals Issues Statement Reaffirming Benefit/Risk Profile of NUPLAZID Following A Recent Negative Article From CNN,2018-04-27 08:00:00-04:00,ACAD,negative
12758.0,"Benzinga Pro's Most-Searched Tickers For Afternoon Of Thurs., Apr. 26, 2018",2018-04-26 12:36:00-04:00,ACAD,neutral
12759.0,"Hearing JPMorgan Out With Comments On Acadia, Says They Spoke To Management Regarding The Recent CNN Report On Nuplazid And They Believe That The Product Has A Low Or Zero Chance Of Being Pulled From The Market",2018-04-26 09:52:00-04:00,ACAD,neutral
12760.0,"Benzinga's Daily Biotech Pulse: Catabasis Soars On Trial Results, Eloxx Listing, Biomarin Earnings",2018-04-26 08:07:00-04:00,ACAD,neutral
12761.0,36 Biggest Movers From Yesterday,2018-04-26 04:53:00-04:00,ACAD,neutral
12762.0,"'On $ACAD, I reached out to FDA to clarify today's CNN report. Confirmed.'",2018-04-25 16:46:00-04:00,ACAD,positive
12763.0,Acadia Pharma Shares Not Responding Following Recent Tweet 'The article implies the FDA is conducting a new investigation.  An email to @JohnCendptsfrom the FDA says that they are reviewing available information.  Big difference....',2018-04-25 15:23:00-04:00,ACAD,positive
12764.0,"BZ Note: Acadia Shares' Weakness Today Attributed To CNN's Article On FDA Concerns About Its Nuplazid Treatment; CNN Previously Reported On FDA Concerns April 9th, But Today Reports FDA Re-Examining Its Safety",2018-04-25 14:39:00-04:00,ACAD,positive
12765.0,"Acadia Shares Dropping On CNN Article Titled 'FDA re-examines safety of controversial new drug', CNN Reports Rep. DeLauro Has Concerns With Acadia Pharmaceutical Regarding  Nuplazid",2018-04-25 13:55:00-04:00,ACAD,positive
12766.0,"San Diego Union-Tribune Reports 'Acadia's Parkinson drug risk adequately disclosed, says FDA'",2018-04-11 09:41:00-04:00,ACAD,negative
12767.0,40 Biggest Movers From Yesterday,2018-04-10 04:21:00-04:00,ACAD,neutral
12768.0,Mid-Afternoon Market Update: Crude Oil Up Over 2%; Therapix Biosciences Shares Spike Higher,2018-04-09 14:32:00-04:00,ACAD,negative
12769.0,Acadia Shares Hurting On Reports Of Nuplazid Deaths,2018-04-09 13:15:00-04:00,ACAD,negative
12770.0,31 Stocks Moving In Monday's Mid-Day Session,2018-04-09 12:32:00-04:00,ACAD,neutral
12771.0,Mid-Day Market Update: Dow Rises 250 Points; Menlo Therapeutics Shares Slide,2018-04-09 12:09:00-04:00,ACAD,positive
12772.0,Acadia Shares Fall 15% Premarket; CNN Article Reporting Deaths from Nuplazid,2018-04-09 08:32:00-04:00,ACAD,positive
12773.0,50 Biggest Movers From Yesterday,2018-03-01 04:59:00-05:00,ACAD,neutral
12774.0,40 Stocks Moving In Wednesday's Mid-Day Session,2018-02-28 12:20:00-05:00,ACAD,neutral
12775.0,Mid-Morning Market Update: Markets Open Higher; Lowe's Profit Misses Views,2018-02-28 10:16:00-05:00,ACAD,positive
12776.0,"Adam Feuerstein Tweets: Acadia Pharma raised the price of its only drug twice but quarterly sales still disappoint statnews.com/2018/02/28/aca… uh oh, $ACAD.",2018-02-28 08:57:00-05:00,ACAD,negative
12777.0,31 Stocks Moving In Wednesday's Pre-Market Session,2018-02-28 08:06:00-05:00,ACAD,neutral
12778.0,12 Stocks Moving In Tuesday's After-Hours Session,2018-02-27 17:50:00-05:00,ACAD,neutral
12779.0,Acadia Pharma Sees 2018 Sales $225M-$270M vs. $260.7M Est.,2018-02-27 16:13:00-05:00,ACAD,neutral
12780.0,"Acadia Pharma Reports Q4 EPS $(0.55) vs. $(0.58) Est., Sales $43.6M vs. $44.32M ESt.",2018-02-27 16:12:00-05:00,ACAD,neutral
12781.0,ACADIA Pharmaceuticals Q4 Earnings Preview,2018-02-27 11:37:00-05:00,ACAD,neutral
12782.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-02-25 15:50:00-05:00,ACAD,neutral
12783.0,ACADIA Pharma Shares Up 1.5%; Traders Circulating Tweet From Questionable Source Suggesting Interest In Co. From AstraZeneca,2018-02-01 10:16:00-05:00,ACAD,positive
12784.0,"Cara Therapeutics Shares Up 19.24% As Co. Mentioned In Earlier Opinion Piece As Potential M&A Target; Other Mentions Include: BMRN -0.66%, BLUE +3.87%, ACAD -0.3%, INCY +0.4%",2018-01-24 13:40:00-05:00,ACAD,positive
12785.0,"JP Morgan Healthcare Conference Continues Today, Presenters Include: Bluebird Bio, Agilent, Insulet, Cigna, DexCom, Eli Lilly, LifePoint, Acadia, Alkermes, Juno Therapeutics",2018-01-09 09:02:00-05:00,ACAD,positive
12786.0,4 Biotech Stocks Ready To Crush The Market In 2018,2017-12-27 12:41:00-05:00,ACAD,positive
12787.0,"Piper Jaffray Healthcare Conference 2017 Begins Today, Presenters Include: Civitas Solutions, Insulet, ACADIA Healthcare, Nektar Therapeutics, Quidel, and Arrowhead Pharmaceuticals",2017-11-28 08:57:00-05:00,ACAD,positive
12788.0,H.C. Wainwright: Acadia Is More Than A One-Trick Pony,2017-11-08 12:26:00-05:00,ACAD,neutral
12789.0,"ACADIA Pharmaceuticals Reports Q3 EPS $(0.53) vs $(0.62) Est., Sales $35.6M vs $32.03M Est.",2017-11-07 17:29:00-05:00,ACAD,neutral
12790.0,Acadia Shares Volatile As Co. Says Data In Phase 2 Study Of Pimavanserin Significantly Improved Psychosis In Patients With Alzhehimer's,2017-11-03 13:36:00-04:00,ACAD,positive
12791.0,13D/A From Baker Bros. Shows 22.1% Stake In Acadia Pharmaceuticals,2017-10-16 17:21:00-04:00,ACAD,neutral
12792.0,Benzinga's Option Alert Recap From October 13,2017-10-13 16:34:00-04:00,ACAD,positive
12793.0,Acadia Option Alert: Nov 17 $33 Puts Sweep (3) at the Ask: 2000 @ $1.301 vs 14 OI; Ref=$36.0,2017-10-13 12:46:00-04:00,ACAD,positive
12794.0,"Adam Feuerstein Tweets: I believe Avanir & $ACAD market drugs heavily to nursing homes as way to keep patients docile, easy to care for. You decide if that's OK.",2017-10-13 10:53:00-04:00,ACAD,positive
12795.0,Selling The News In Acadia Pharmaceuticals,2017-10-06 10:59:00-04:00,ACAD,neutral
12796.0,Pros And Cons Of All The News Out Of Acadia Pharma This Week,2017-10-06 08:40:00-04:00,ACAD,neutral
12797.0,Acadia's FDA Breakthrough Designation For Pimavanserin Draws Mixed Response,2017-10-05 14:20:00-04:00,ACAD,neutral
12798.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-10-05 08:05:00-04:00,ACAD,neutral
12799.0,STAT News' Adam Feuerstein Responds To Recent Tweet: '...$ACAD shutting down SERENE bc it doesn't want negative results coming out while ph3 is running. Would make Baker Bros. sad.',2017-10-04 16:35:00-04:00,ACAD,positive
12800.0,"STAT News Adam Feuerstein Tweets 'Oh, by the way, $ACAD is shutting down ph2 study of pimvanserin in Alzheimer's agitation. It's buried at bottom of PR, like data will be.'",2017-10-04 16:15:00-04:00,ACAD,positive
12801.0,"UPDATE: ACADIA Pharma Received Breakthrough Therapy Designation From FDA For Pimavanserin, Will Hold Conf. Call 5pm ET To Discuss Phase III Program",2017-10-04 16:09:00-04:00,ACAD,neutral
12802.0,STAT News Adam Feuerstein Tweets 'Do we need any more proof that Breakthrough Therapy Designation has become a farce? Not after today's $ACAD grant.',2017-10-04 16:08:00-04:00,ACAD,negative
12803.0,ACADIA Pharma Initiates Phase III Study Of Pimavanserin In Dementia Related Psychosis,2017-10-04 16:07:00-04:00,ACAD,neutral
12804.0,"ACADIA Pharma Shares Indicated Up 0.5% Premarket As Traders Circulate Article From UK Paper, 'Market report: AstraZeneca in spotlight as traders revive chatter over bid for US firm Acadia'",2017-09-08 07:35:00-04:00,ACAD,positive
12805.0,"Adamas Pharma's Gocovri Approved, A Welcome Addition To Parkinson's Treatments",2017-08-25 12:03:00-04:00,ACAD,positive
12806.0,Acadia Up 14% After Q2 Beat,2017-08-09 12:42:00-04:00,ACAD,neutral
12807.0,20 Biggest Mid-Day Gainers For Wednesday,2017-08-09 12:36:00-04:00,ACAD,neutral
12808.0,"Acadia Shares Up Big On Strong Sales, Increased Confidence",2017-08-09 12:24:00-04:00,ACAD,positive
12809.0,18 Stocks Moving In Wednesday's Pre-Market Session,2017-08-09 08:19:00-04:00,ACAD,neutral
12810.0,"ACADIA Pharmaceuticals Reports Q2 EPS $(0.55) vs $(0.72) Est., Sales $30.5M vs $20.02M Est.",2017-08-08 16:25:00-04:00,ACAD,neutral
12811.0,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",2017-08-07 07:19:00-04:00,ACAD,positive
12812.0,"ACADIA Pharmaceuticals Spokesperson, Responding To Inquiry Of Earlier Takeover Chatter, Tells Benzinga The Co. Does Not Respond To Marketplace Rumors",2017-08-04 14:17:00-04:00,ACAD,neutral
12813.0,ACADIA Pharma Shares Spike ~$0.60-$0.70 Over Last Min. As Traders Circulating Takeover Chatter In Name,2017-08-04 09:51:00-04:00,ACAD,positive
12815.0,"Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma",2017-06-22 07:06:00-04:00,ACAD,neutral
12816.0,"ACADIA Pharma Shares Spike ~$0.90 Over Last Min, Now Pulling Back From Session Highs; Traders Circulating Chatter Of Biogen Interest",2017-06-21 10:09:00-04:00,ACAD,positive
12817.0,"Companies Holding Shareholder Meetings Today Include: Acadia Healthcare, Big Lots, Arconic, Axon Enterprise, AK Steel, Cinemark, Green Dot, Fitbit, Ligand Pharmaceuticals, Norwegian Cruise Line, Raytheon, & Tiffany",2017-05-25 08:38:00-04:00,ACAD,neutral
12818.0,Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher,2017-05-10 12:00:00-04:00,ACAD,negative
12819.0,"ACADIA Pharmaceuticals Reports Q1 EPS $(0.72) vs $(0.73) Est., Sales $15.286M vs $15.19M Est.",2017-05-09 17:26:00-04:00,ACAD,neutral
12820.0,"Needham Healthcare Conference Concludes Today; Presenters Include Alnylam, TRACON Pharma, And ACADIA Pharma",2017-04-05 08:40:00-04:00,ACAD,neutral
12821.0,"Needham Healthcare Conference Begins Today; Presenters Include vTv Therapeutics, AtriCure, Heron Therapeutics, The Medicines, Aeri Pharmaceuticals",2017-04-04 08:34:00-04:00,ACAD,neutral
12822.0,"Raymond James Institutional Investors Conference Continues Today; Presenters Include Arrow Electronics, Insulet, JB Hunt, HCA Holdings, Palo Alto, Alexion, Moody's, Pier 1, & ACADIA Pharama",2017-03-07 08:57:00-05:00,ACAD,neutral
12823.0,"Cowen Annual Healthcare Conference Begins Today; Presenters Include Insulet, PARAXEL, Zoetis, Alexion, Bristol-Myers, Acadia, Alnylam, Axovant, Ardelyx, Aurinia Pharma, And Puma Biotech",2017-03-06 08:39:00-05:00,ACAD,neutral
12824.0,"ACADIA Pharma Reports Q4 EPS $(0.65) In-line, Sales $11.962M vs $9.05M Est.",2017-02-28 16:08:00-05:00,ACAD,neutral
12825.0,Q4 2016 Real-Time Call Brief,2017-02-27 19:00:00-05:00,ACAD,neutral
12826.0,Traders Circulating Seeking Alpha Article by ONeil Trader 'Acadia Pharmaceuticals: Still Room To Run? Or To Get Acquired?',2017-02-17 10:24:00-05:00,ACAD,neutral
12827.0,Price Bump From M&A Rumors Earns Acadia A Vetr Downgrade,2017-02-15 17:03:00-05:00,ACAD,neutral
12828.0,ACADIA Shares Up $0.80 Over Last Min as Hearing Dealreporter Suggesting J&J Could Approach Co.,2017-02-14 13:26:00-05:00,ACAD,positive
12829.0,Benzinga's Option Alert Recap From February 6,2017-02-06 16:52:00-05:00,ACAD,positive
12830.0,Option Alert: Acadia Pharm Mar 42.0 Calls Sweep: 531 @  ASK  $1.975: 531 traded vs 759 OI:  Earnings 2/27 After Close (est)  $37.27 Ref,2017-02-06 11:20:00-05:00,ACAD,positive
12831.0,The Market In 5 Minutes: One For The Thumb,2017-02-06 09:03:00-05:00,ACAD,neutral
12832.0,Wall Street's M&A Chatter From February 3-6,2017-02-06 06:40:00-05:00,ACAD,neutral
12833.0,ACADIA Spokesperson Tells Benzinga The Company Does Not Comment On Rumors In The Marketplace,2017-02-03 16:12:00-05:00,ACAD,neutral
12834.0,ACADIA Shares Spike Over Notable Resistance Level at $36 Amid Unconfirmed Chatter; BZ NOTE: Price Has Struggled Over $36 At Least 7 Times Over Last Year; Watch for Profit Taking Above $36,2017-02-03 11:26:00-05:00,ACAD,positive
12835.0,ACADIA Shares Spike ~6% Over Last Min Amid Unconfirmed Chatter of Takeover Interest,2017-02-03 11:23:00-05:00,ACAD,positive
12836.0,Acadia Pharma Spikes to High of $37.74 on Volume,2017-02-03 11:21:00-05:00,ACAD,neutral
12837.0,"Ladenburg Thalmann Assumes ACADIA Pharmaceuticals at Buy, Lowers Target from $49 to $48.00",2017-02-02 07:31:00-05:00,ACAD,negative
12838.0,Acadia Shares Move Slightly Lower; Traders Attributing To Negative Seeking Alpha Blog Post Being Passed Around,2017-01-17 14:21:00-05:00,ACAD,negative
12839.0,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle",2017-01-05 09:13:00-05:00,ACAD,negative
12840.0,Wall Street's M&A Chatter From January 4,2017-01-05 06:51:00-05:00,ACAD,neutral
12841.0,Acadia Pharmaceuticals Regarding Takeover Chatter Says It 'Does Not Comment About Rumors In The Marketplace',2017-01-04 13:14:00-05:00,ACAD,neutral
12842.0,Option Alert: Acadia Jan 32.5 Calls Sweep: 595 @  ASK  $1.20: 1016 traded vs 1072 OI:  Earnings 2/27 After Close (est)  $30.79 Ref,2017-01-04 11:16:00-05:00,ACAD,positive
12843.0,Acadia Shares Spike ~$0.30 Higher Over Last Min. as Traders Circulating Unconfirmed Takeover Chatter,2017-01-04 11:04:00-05:00,ACAD,positive
12844.0,Vetr Still Bullish On Acadia Despite Downgrade,2016-12-28 07:18:00-05:00,ACAD,neutral
12845.0,Acadia's Positive Data News May Have Triggered Short Squeeze,2016-12-20 13:31:00-05:00,ACAD,positive
12846.0,15 Biggest Mid-Day Gainers For Tuesday,2016-12-20 12:43:00-05:00,ACAD,neutral
12847.0,ACADIA Meets Primary Endpoint Alzheimer's Disease Exploratory Study; Stock Rallys,2016-12-20 10:27:00-05:00,ACAD,neutral
12848.0,"Adam Feuerstein @adamfeuerstein Tweet $ACAD says time point for primary endpoint was always 6 wks, not 12 wks, but ClinicalTrials.gov listing says 12 weeks, so….?",2016-12-20 08:59:00-05:00,ACAD,neutral
12849.0,"Adam Feuerstein Tweets: $ACAD sell-side squawks so far, summarized: No one thought the ADP study would work so even a tiny, clinically meaningless signal is upside.",2016-12-20 08:39:00-05:00,ACAD,negative
12850.0,18 Stocks Moving In Tuesday's Pre-Market Session,2016-12-20 08:32:00-05:00,ACAD,neutral
12851.0,"Adam Feuerstein Tweets: $ACAD spins a pimvanserin failure to look positive, says @AF_biotech. Shape-shifting ph2 tend to do that",2016-12-20 07:40:00-05:00,ACAD,positive
12852.0,ACADIA Pharmaceuticals Meets Primary Endpoint In Reduction Of Psychosis Versus Placebo By NPI-NH Psychosis Score In Phase 2 Exploratory Study,2016-12-20 07:06:00-05:00,ACAD,neutral
12853.0,6 Biotechs Still Awaiting December Catalysts,2016-12-13 13:53:00-05:00,ACAD,neutral
12854.0,ACADIA Pharmaceuticals Shares Down 6.23% Mid-Morning On Above-Average Volume Amid Biotech Sell-Off Inspired By Trump Drug-Pricing Comments,2016-12-07 11:21:00-05:00,ACAD,positive
12855.0,5 BioPharma Catalysts Expected Around Christmas,2016-11-27 08:56:00-05:00,ACAD,neutral
12856.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2016-11-22 01:02:00-05:00,ACAD,positive
12857.0,Option Alert: ACAD Jan17 35.0 Calls: 3000 @  ASK  $2.25: 3097 traded vs 9444 OI:  Earnings 2/27 After Close (est)  $28.96 Ref,2016-11-21 10:42:00-05:00,ACAD,positive
12858.0,ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients With Negative Symptoms of Schizophrenia,2016-11-15 09:03:00-05:00,ACAD,negative
12859.0,Benzinga's Top Initiations,2016-11-11 09:34:00-05:00,ACAD,positive
12860.0,"The Market In 5 Minutes: You Don't Really Care For Music, Do You?",2016-11-11 08:57:00-05:00,ACAD,negative
12861.0,"Goldman Sachs Initiates Coverage On ACADIA Pharmaceuticals Inc. - Common Stock at Neutral, Announces $28.00",2016-11-11 06:34:00-05:00,ACAD,neutral
12862.0,4 Election-Proof Stocks: Biotech And Software Take The Lead,2016-11-08 15:22:00-05:00,ACAD,neutral
12863.0,15 Biggest Mid-Day Gainers For Tuesday,2016-11-08 13:42:00-05:00,ACAD,neutral
12864.0,Technical Alert: Endo Pharmaceuticals Higher Q3 Report And Raised Guidance,2016-11-08 11:54:00-05:00,ACAD,positive
12865.0,Technical Alert: Acadia Pharmaceuticals Higher After Q3 Report,2016-11-08 11:51:00-05:00,ACAD,positive
12866.0,Acadia's Valuation Looks Pretty Attractive Right Now: Bank Of America Upgrades To Buy,2016-11-08 10:55:00-05:00,ACAD,positive
12867.0,Benzinga's Volume Movers,2016-11-08 10:41:00-05:00,ACAD,neutral
12868.0,The Market In 5 Minutes: Election Day Has Finally Arrived,2016-11-08 09:00:00-05:00,ACAD,neutral
12869.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-11-08 08:34:00-05:00,ACAD,neutral
12870.0,Bank of America Upgrades ACADIA Pharmaceuticals Inc. - Common Stock to Buy,2016-11-08 07:17:00-05:00,ACAD,neutral
12871.0,"ACADIA Pharma Reports Q3 EPS $(0.61) vs $(0.56) Est., Sales $5.3M vs $2.9M Est.",2016-11-07 16:46:00-05:00,ACAD,neutral
12872.0,16 Stocks Moving In Monday's Pre-Market Session,2016-11-07 08:34:00-05:00,ACAD,neutral
12873.0,ACADIA Pharmaceuticals Initiates Phase III Trial For Pimavanserin,2016-11-03 09:07:00-04:00,ACAD,neutral
12874.0,Acadia Healthcare Shares Spike Higher Over $24 Level as Traders Discussing Unconfirmed Takeover Chatter,2016-10-21 11:39:00-04:00,ACAD,positive
12875.0,Benzinga's Top Initiations,2016-10-19 09:19:00-04:00,ACAD,positive
12876.0,Roth Capital Assumes ACADIA Pharmaceuticals Inc. - Common Stock at Neutral,2016-10-19 08:21:00-04:00,ACAD,neutral
12877.0,Watch These 7 Huge Call Purchases In Thursday Trade,2016-10-06 02:52:00-04:00,ACAD,positive
12878.0,Option Alert: ACAD Jan17 35.0 Calls: 675 @  ASK  $3.40: 982 traded vs 7938 OI:  Earnings 11/3  $29.11 Ref,2016-10-05 10:16:00-04:00,ACAD,positive
12879.0,Acadia Pharmaceuticals Lower For Fifth Day In A Row,2016-10-04 13:40:00-04:00,ACAD,negative
12880.0,"Leerink Swann Initiates Coverage on ACADIA Pharmaceuticals at Market Perform, Announces $34.00 PT",2016-10-04 07:13:00-04:00,ACAD,neutral
12881.0,The Market In 5 Minutes: OPEC's Deal And Gary Johnson's Moment,2016-09-29 09:00:00-04:00,ACAD,neutral
12882.0,"Benzinga's M&A Chatter for Wednesday September 28, 2016",2016-09-28 21:22:00-04:00,ACAD,neutral
12883.0,Acadia Shares Popping on Volume ; Hearing DealReporter Says Allergan Could Bid for Co,2016-09-28 13:05:00-04:00,ACAD,positive
12884.0,5 Stocks Which Plummeted Three Days On Increasing Volume,2016-09-07 12:23:00-04:00,ACAD,neutral
12885.0,Technical Alert: ACADIA Pharmaceuticals Fails To Hold New Offering Share Price Of $33,2016-08-10 12:05:00-04:00,ACAD,positive
12886.0,Acadia Pharmaceuticals +$0.46 Premarket @$33.80 After Co Prices 6.06M Share Offering @$33.00/Share,2016-08-10 07:37:00-04:00,ACAD,positive
12887.0,There Have Been 20 Secondary Offerings Over The Last 2 Days,2016-08-09 14:05:00-04:00,ACAD,neutral
12888.0,20 Biggest Mid-Day Losers For Tuesday,2016-08-09 13:15:00-04:00,ACAD,negative
12889.0,22 Stocks Moving In Tuesday's Pre-Market Session,2016-08-09 08:48:00-04:00,ACAD,neutral
12890.0,ACADIA Pharmaceuticals Reports Proposed Public Offering of Common Stock Of $200M,2016-08-08 16:15:00-04:00,ACAD,neutral
12891.0,ACADIA Pharmaceuticals Reports Q2 EPS $(0.63) vs. Est. $(0.49),2016-08-04 17:46:00-04:00,ACAD,neutral
12892.0,These were The Top 10 Trending Stocks This Week,2016-07-01 16:22:00-04:00,ACAD,positive
12893.0,Biotechs Are Ripping Following IPAB Ruling,2016-06-22 11:31:00-04:00,ACAD,neutral
12894.0,Benzinga's Top Downgrades,2016-06-22 09:04:00-04:00,ACAD,positive
12895.0,Bank of America Downgrades ACADIA Pharmaceuticals to Neutral,2016-06-22 07:43:00-04:00,ACAD,neutral
12896.0,Acadia Pharmaceuticals May Be Subject Of A Bidding War,2016-06-06 12:21:00-04:00,ACAD,negative
12897.0,"Must Watch Stocks for June 6, 2016",2016-06-06 04:36:00-04:00,ACAD,neutral
12898.0,"AstraZeneca, Teva, Biogen, Allergan Said to be Potential Bidders for Acadia -Daily Mail",2016-06-03 18:38:00-04:00,ACAD,neutral
12899.0,ACADIA Pharmaceuticals: NUPLAZID™ (pimavanserin) Now Available for Treatment of Hallucinations And Delusions Associated with Parkinson's Disease Psychosis,2016-05-31 08:00:00-04:00,ACAD,neutral
12900.0,15 Stocks Moving In Friday's Pre-Market Session,2016-05-06 08:22:00-04:00,ACAD,neutral
12901.0,"Acadia Pharmaceuticals Shares Move Higher; May be Attributed to Street.com Article Mentioning Teva, Biogen as Potential Buyers",2016-05-05 15:29:00-04:00,ACAD,positive
12902.0,Leerink Swann Downgrades ACADIA Pharmaceuticals to Market Perform,2016-05-03 06:43:00-04:00,ACAD,neutral
12903.0,Acadia Pharmaceuticals Pops And Drops,2016-05-02 10:42:00-04:00,ACAD,neutral
12904.0,10 Stocks Moving In Monday's Pre-Market Session,2016-05-02 08:28:00-04:00,ACAD,neutral
12905.0,"ACADIA Pharmaceuticals Resume Trading, Up 8% @$35.00 Following Friday's FDA Approval of  NUPLAZID",2016-05-02 07:34:00-04:00,ACAD,positive
12906.0,Option Alert: ACAD May16 16.0 Puts Sweep: 590 @  ASK  $0.25: 700 traded vs 72 OI:  Earnings 5/5  $33.64 Ref,2016-04-15 11:39:00-04:00,ACAD,positive
12907.0,Adam Feuerstein @adamfeuerstein Tweet: Leerink included $ACAD on list of top 10 partnership/acquisition candidates this morning,2016-04-14 09:54:00-04:00,ACAD,positive
12908.0,Baker Brothers Ups Acadia Pharma Stake,2016-04-04 10:41:00-04:00,ACAD,neutral
12909.0,Mid-Day Market Update: ACADIA Pharmaceuticals Rises Following FDA Panel Vote; Verint Systems Shares Slide,2016-03-30 12:05:00-04:00,ACAD,positive
12910.0,Benzinga's Volume Movers,2016-03-30 10:08:00-04:00,ACAD,neutral
12911.0,Mid-Morning Market Update: Markets Open Higher; Lululemon Earnings Beat Views,2016-03-30 09:45:00-04:00,ACAD,neutral
12912.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-03-30 08:15:00-04:00,ACAD,neutral
12913.0,Acadia Continues Huge Rise Following FDA Panel Vote,2016-03-30 07:52:00-04:00,ACAD,positive
12914.0,Acadia Pharmacauticals +30% Premarket @$30.96; FDA Panel Backed NUPLAZID for Treatment of Psychosis Related to Parkinson's Disease,2016-03-30 06:21:00-04:00,ACAD,neutral
12915.0,"ACADIA Shares Spiking Higher To $29.87/Share, Up 25%",2016-03-29 17:46:00-04:00,ACAD,positive
12916.0,"ACADIA To Resume Quotes At 5:40pm, Resume Trade At 5:45pm",2016-03-29 17:23:00-04:00,ACAD,neutral
12917.0,ACADIA Announces FDA Panel Has Voted 12-2 Benefits of NUPLAZID for Treatment of Psychosis Related to Parkinson's Outweigh Risks,2016-03-29 17:14:00-04:00,ACAD,positive
12918.0,Majority Of FDA Panel Vote Says Acadia's Drug Benefits For Parkinson's Disease Psychosis Outweigh RIsks,2016-03-29 15:38:00-04:00,ACAD,positive
12919.0,FDA Advisory Committee Votes 12-2 in Favor of Effectiveness of  Acadia's Nuplazid NDA for Treatment of Parkinson's Disease Psychosis -Reuters,2016-03-29 14:55:00-04:00,ACAD,positive
12920.0,FDA Advisory Committee to Review ACADIA's NUPLAZID New Drug Application for the Treatment of Parkinson's Disease Psychosis,2016-03-29 07:06:00-04:00,ACAD,neutral
12921.0,ACADIA Shares Halted News Pending,2016-03-29 07:01:00-04:00,ACAD,positive
12922.0,Mid-Afternoon Market Update: Dow Jumps 50 Points; Pandora Shares Slide,2016-03-28 14:38:00-04:00,ACAD,positive
12923.0,Acadia Surges 22% After FDA Releases Briefing Documents,2016-03-28 13:27:00-04:00,ACAD,neutral
12924.0,"ACADIA Pharma Having Big Monday On FDA News, But Still Down Big YTD",2016-03-28 12:03:00-04:00,ACAD,neutral
12925.0,Benzinga's Volume Movers,2016-03-28 10:30:00-04:00,ACAD,neutral
12926.0,10 Stocks Moving In Monday's Pre-Market Session,2016-03-28 08:26:00-04:00,ACAD,neutral
12927.0,Acadia Pharmacauticals +16% Premarket @$23.65; FDA Announced Friday Single Pivotal Study Established Statistical Evidence That Pimavanserin 40 Mg Effective as Treatment for Parkinson's Disease Psychosis,2016-03-28 07:04:00-04:00,ACAD,positive
12928.0,Mid-Afternoon Market Update: US Stocks Gain; Markit Shares Surge,2016-03-21 14:41:00-04:00,ACAD,positive
12929.0,"ACADIA Pharma Reports Q4 EPS $(0.45) vs $(0.38) Est., Sales $17K vs $60K Est.",2016-02-29 07:02:00-05:00,ACAD,neutral
12930.0,Why Are Analysts So Bullish On This Tumbling Biotech Company?,2016-02-08 10:32:00-05:00,ACAD,neutral
12931.0,Benzinga's Top Initiations,2016-02-08 09:50:00-05:00,ACAD,positive
12932.0,"Bank of America Initiates Coverage on ACADIA Pharmaceuticals at Buy, Announces $40.00 PT",2016-02-08 07:12:00-05:00,ACAD,neutral
12933.0,Acadia Pharmaceuticals Are Spiking,2016-02-01 08:55:00-05:00,ACAD,neutral
12934.0,ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID for the Treatment of Parkinson's Disease Psychosis,2016-01-29 16:05:00-05:00,ACAD,neutral
12935.0,ACADIA Names Dr. James Owen Chief Medical Officer,2016-01-25 09:03:00-05:00,ACAD,neutral
12936.0,Benzinga's Top Upgrades,2016-01-22 08:50:00-05:00,ACAD,positive
12937.0,Piper Jaffray Upgrades ACADIA Pharmaceuticals to Overweight,2016-01-22 06:39:00-05:00,ACAD,negative
12938.0,Here's Why There's Been A Rush Of Biotech Offerings,2016-01-07 11:32:00-05:00,ACAD,neutral
12939.0,ACADIA Pharmaceuticals Prices ~10.344M Share Offering @$29.00/Share,2016-01-07 04:12:00-05:00,ACAD,positive
12940.0,Notable Buy-Side Biotech Analyst Brad Loncar Notes Heavy Biotech Offerings Taking Place After Hours In Tweet,2016-01-05 16:15:00-05:00,ACAD,neutral
12941.0,ACADIA Reports $300M Offering,2016-01-05 16:07:00-05:00,ACAD,neutral
12942.0,"ACADIA Pharmaceuticals Appoints Srdjan (Serge) Stankovic, M.D., M.S.P.H., as EVP, Head of Research and Development",2015-11-30 09:02:00-05:00,ACAD,neutral
12943.0,ACADIA Pharmaceuticals Announces FDA Priority Review of NUPLAZID New Drug Application for Parkinson's Disease Psychosis,2015-11-02 08:00:00-05:00,ACAD,neutral
12944.0,Amgen And Biogen Lead Short Interest Surge In Biotechs,2015-09-14 16:01:00-04:00,ACAD,positive
12945.0,Morning Market Gainers,2015-09-03 09:42:00-04:00,ACAD,neutral
12946.0,Benzinga's Top #PreMarket Gainers,2015-09-03 08:14:00-04:00,ACAD,positive
12947.0,Acadia Pharma Appoints Steve Davis As CEO,2015-09-03 07:03:00-04:00,ACAD,neutral
12948.0,ACADIA Pharma Names Steve Davis CEO,2015-09-03 07:01:00-04:00,ACAD,neutral
12949.0,Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline,2015-08-27 15:06:00-04:00,ACAD,neutral
12950.0,"8- from Acadia Pharma Shows Co.'s Swiss Subsidiary Entered Co-Op Deal, Product Schedule with BASF Pharma",2015-08-21 16:33:00-04:00,ACAD,neutral
12951.0,Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing,2015-08-07 13:27:00-04:00,ACAD,negative
12952.0,"Piper Jaffray Downgrades ACADIA Pharmaceuticals to Neutral, Raises PT to $48.00",2015-08-07 07:20:00-04:00,ACAD,neutral
12953.0,ACADIA Pharmaceuticals Reports Q2 EPS of $(0.39) vs $(0.33) Est; Revenue of $1.0K vs $60.0K Est,2015-08-06 19:13:00-04:00,ACAD,neutral
12954.0,ACADIA Pharmaceuticals Shows Integrated Data from Its Phase III Program with NUPLAZID for Parkinson's Disease Psychosis at the 19th International Congress of Parkinson's Disease and Movement Disorders,2015-06-16 09:01:00-04:00,ACAD,neutral
12955.0,"Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter",2015-05-18 13:38:00-04:00,ACAD,positive
12956.0,Benzinga's Top Initiations,2015-04-16 09:45:00-04:00,ACAD,positive
12957.0,"Acadia Will Outperform, Worth $48/Share Says Leerink",2015-04-16 09:39:00-04:00,ACAD,positive
12958.0,Leerink Swann Initiates ACADIA Pharmaceuticals At Outperform,2015-04-16 08:26:00-04:00,ACAD,neutral
12959.0,"Leerink Swann Initiates Coverage on ACADIA Pharmaceuticals at Outperform, Announces $48.00 PT",2015-04-16 06:09:00-04:00,ACAD,neutral
12960.0,Morning Market Losers,2015-03-12 09:56:00-04:00,ACAD,negative
12961.0,Benzinga's Top #PreMarket Losers,2015-03-12 08:20:00-04:00,ACAD,negative
12962.0,"Wednesday's After-Hours Movers: Shake Shack, Box And Others Fall Following Earnings",2015-03-11 18:01:00-04:00,ACAD,negative
12963.0,"Hearing ACADIA Pharma Will Submit NUPLAZID NDA During Second Half, Cites Extra Time to Close Preparation of Systems",2015-03-11 16:28:00-04:00,ACAD,neutral
12965.0,Hearing Acadia Rises As Company Cancels Out of Roth Conference,2015-03-10 13:47:00-04:00,ACAD,negative
12966.0,ACADIA Pharma Reports Q4 EPS $(0.28),2015-02-26 16:48:00-05:00,ACAD,neutral
12967.0,"H.C. Wainwright Initiates Coverage on ACADIA Pharmaceuticals at Buy, Announces $50.00 PT",2015-02-24 07:22:00-05:00,ACAD,neutral
12968.0,"Roth Capital Reinstates Buy on ACADIA Pharmaceuticals, Announces $42.00 PT",2015-02-06 04:54:00-05:00,ACAD,neutral
12969.0,"Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals And Raptor Pharmaceutical",2015-02-01 12:54:00-05:00,ACAD,positive
12970.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2,2015-01-12 11:03:00-05:00,ACAD,neutral
12971.0,Benzinga's Top Initiations,2014-11-21 08:21:00-05:00,ACAD,positive
12972.0,Cowen & Company Initiates ACADIA Pharmaceuticals At Outperform,2014-11-21 08:07:00-05:00,ACAD,neutral
12973.0,"Cowen & Company Initiates Coverage on ACADIA Pharmaceuticals Inc. at Outperform, Announces $46.00 PT",2014-11-21 06:24:00-05:00,ACAD,neutral
12974.0,"Earnings Scheduled For November 10, 2014",2014-11-10 05:36:00-05:00,ACAD,neutral
12975.0,Benzinga's Volume Movers,2014-09-02 10:25:00-04:00,ACAD,neutral
12976.0,ACADIA Pharma Receives FDA Breakthrough Therapy Designation For NUPLAZID ,2014-09-02 09:02:00-04:00,ACAD,neutral
12977.0,ACADIA Pharmaceuticals Inc. Reports Q2 EPS of $(0.22) Which May Not Compare $(0.19) Est; Revenue of $28.0K Which May Not Compare $260.0K Est,2014-08-05 16:18:00-04:00,ACAD,neutral
12978.0,Acadia Pharma Announces Stephen Davis CFO,2014-07-15 09:02:00-04:00,ACAD,neutral
12979.0,"ACADIA Pharmaceuticals Announces Stephen Davis As Executive VP, CFO And Chief Business Officer",2014-07-15 09:01:00-04:00,ACAD,neutral
12980.0,4 Biotech Stocks Worth A Look Ahead Of FDA Approvals,2014-07-03 10:36:00-04:00,ACAD,positive
12981.0,Benzinga's Top Initiations,2014-05-15 08:02:00-04:00,ACAD,positive
12982.0,"JP Morgan Initiates Coverage on ACADIA Pharmaceuticals Inc. at Overweight, Announces $33.00 PT",2014-05-15 06:09:00-04:00,ACAD,neutral
12983.0,ACADIA Pharmaceuticals Inc. Reports Q1 EPS of $(0.19) vs $(0.13) Est,2014-05-06 16:41:00-04:00,ACAD,neutral
12984.0,13G Filing from Viking Global Investors on Acadia Pharma Shows Unch Stake of 5%,2014-05-05 15:21:00-04:00,ACAD,neutral
12985.0,"Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE",2014-03-05 10:14:00-05:00,ACAD,negative
12986.0,ACADIA Pharmaceuticals Prices 6.4M Share Offering at $28.50/Share ,2014-03-04 19:52:00-05:00,ACAD,positive
12987.0,ACADIA Pharmaceuticals Announces $150M Proposed Public Offering of Common Stock,2014-03-03 16:01:00-05:00,ACAD,neutral
12988.0,ACADIA Pharmaceuticals Inc. Reports Q4 EPS of $(0.13) vs $(0.14) Est; Revenue of $37.0K vs $310.0K Est,2014-02-27 16:06:00-05:00,ACAD,neutral
12989.0,Acadia Shares Move Lower; May be Attributed to Negative Seeking Alpha Post,2014-01-07 10:14:00-05:00,ACAD,negative
12990.0,ACADIA Initiates Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis ,2013-11-14 09:19:00-05:00,ACAD,neutral
12991.0,"ACADIA Pharmaceuticals Inc. Reports Q3 EPS of $(0.12), Inline; Revenue of $240.0K vs $300.0K Est",2013-11-06 16:29:00-05:00,ACAD,neutral
12992.0,ACADIA Announces Publication of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin ,2013-11-01 06:01:00-04:00,ACAD,neutral
12993.0,Benzinga's Volume Movers ,2013-10-10 10:33:00-04:00,ACAD,neutral
12994.0,Benzinga's Top Pre-Market Gainers,2013-10-10 08:16:00-04:00,ACAD,positive
12995.0,"Adam Feuerstein Tweet on Acadia: 'None of the docs on Cowen panel taking place right now are slamming pimvanserin, according to a source on the scene'",2013-10-08 11:08:00-04:00,ACAD,neutral
12996.0,"Downside in ACADIA Pharma Shares Intensifies as Price Failed to Break Over 20-day SMA, Stock Now Down 14+% to Under $23.75",2013-10-08 10:44:00-04:00,ACAD,negative
12997.0,Acadia Shares Fall 12%; May be Attributed to Report of Doctor on Cowen Panel who is Negative on Pimavanserin,2013-10-08 10:38:00-04:00,ACAD,negative
12998.0,"ACADIA Pharma Names Terrence Moore Exec VP, CCO",2013-08-19 09:03:00-04:00,ACAD,neutral
12999.0,UPDATE: MLV & Co. Downgrades ACADIA Pharmaceuticals on Valuation,2013-08-07 08:56:00-04:00,ACAD,neutral
13000.0,Benzinga's Top Downgrades,2013-08-07 07:45:00-04:00,ACAD,positive
13001.0,"McNicoll Lewis Vlak Downgrades ACADIA Pharmaceuticals Inc. to Hold, Raises PT to $20.00",2013-08-07 07:28:00-04:00,ACAD,neutral
13002.0,ACADIA Pharmaceuticals Inc. Reports Q2 EPS of $(0.11) vs $(0.09) Est; Revenue of $451.0K vs $450.0K Est,2013-08-06 16:01:00-04:00,ACAD,neutral
13003.0,"Stocks to Watch for August 1, 2013",2013-08-01 11:16:00-04:00,ACAD,neutral
13004.0,ACADIA Pharmaceuticals Added to Russell 2000 Index ,2013-07-01 09:02:00-04:00,ACAD,neutral
13005.0,"ACADIA Issues Multiple Presentations of Data from Trial of Pimavanserin, Says Long-Term Usage Safe, Well Tolerated",2013-06-18 09:06:00-04:00,ACAD,positive
13006.0,ACADIA Pharmaceuticals Announces Presentations of Data From Phase III Pimavanserin Program,2013-06-18 09:03:00-04:00,ACAD,neutral
13007.0,ACADIA Pharma Shares Move Higher as JMP Boosted Price Target from $16 to $27,2013-06-14 09:37:00-04:00,ACAD,positive
13008.0,"Market Wrap for Monday, June 10: Stocks Little Changed in Quiet Trade ",2013-06-10 16:47:00-04:00,ACAD,neutral
13009.0,Afternoon Market Gainers,2013-06-10 13:45:00-04:00,ACAD,neutral
13010.0,Benzinga's Volume Movers,2013-06-10 11:27:00-04:00,ACAD,neutral
13011.0,"Stocks to Watch for June 07, 2013",2013-06-07 09:44:00-04:00,ACAD,neutral
13012.0,"Market Wrap for Thursday, June 6: Stocks Reverse Mid-Day; Rally to Close at Session Highs ",2013-06-06 16:33:00-04:00,ACAD,neutral
13013.0,Afternoon Market Gainers,2013-06-06 15:09:00-04:00,ACAD,neutral
13014.0,ACADIA Pharmaceuticals Announces Advancement by Allergan of Novel Glaucoma Compound into Preclinical Development ,2013-06-03 09:05:00-04:00,ACAD,positive
13015.0,ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock ,2013-05-20 16:13:00-04:00,ACAD,positive
13016.0,"Mid-Morning Market Update: Markets Fall, Yahoo To Acquire Tumblr",2013-05-20 10:43:00-04:00,ACAD,neutral
13017.0,"U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying",2013-05-18 15:54:00-04:00,ACAD,neutral
13018.0,ACADIA Pharma Prices 8M Shares at $12.50/Share,2013-05-15 08:04:00-04:00,ACAD,positive
13019.0,ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock ,2013-05-14 16:01:00-04:00,ACAD,neutral
13020.0,"ACADIA Pharmaceuticals Inc. Reports Q1 EPS of $(0.08), Inline; Revenue of $417.0K vs $450.0K Est",2013-05-07 16:54:00-04:00,ACAD,neutral
13021.0,"Benzinga Market Primer: Tuesday, May 7",2013-05-07 06:29:00-04:00,ACAD,neutral
13022.0,Acadia Spikes Higher,2013-04-22 10:39:00-04:00,ACAD,neutral
13023.0,"Unusual Options Activity: Acadia Pharmaceuticals Jan. 2015 12.00/15.00 Call Spread Trades 30,000 Times ",2013-04-18 12:38:00-04:00,ACAD,neutral
13024.0,"Option Alert: Acadia Pharmaceutical January 2015 12/15 Call Spread; Block Trade: 30,000 Contracts; Currently $12.03",2013-04-18 11:48:00-04:00,ACAD,negative
13025.0,"Mid-Morning Market Update: Markets Plummet on Bad Data, Rite Aid Continues to Rally",2013-04-12 10:37:00-04:00,ACAD,negative
13026.0,UPDATE: Jefferies Raises PT on ACADIA Pharmaceuticals Following FDA Discussions,2013-04-12 10:21:00-04:00,ACAD,neutral
13027.0,"Jefferies Maintains Buy on ACADIA Pharmaceuticals Inc., Raises PT to $18.00",2013-04-12 07:15:00-04:00,ACAD,neutral
13028.0,"Market Wrap for Thursday, April 11: Stock Market Rally Continues",2013-04-11 16:10:00-04:00,ACAD,neutral
13029.0,"Mid-Afternoon Market Update: Rite Aid Posts Massive Rally, While Hewlett-Packard Takes a Hit",2013-04-11 15:25:00-04:00,ACAD,neutral
13030.0,Mid-Day Market Update: ACADIA Posts Massive Rally as AMD Falls,2013-04-11 13:18:00-04:00,ACAD,neutral
13031.0,"McNicoll Lewis Vlak Maintains Buy on ACADIA Pharmaceuticals Inc., Raises PT to $18.00",2013-04-11 12:37:00-04:00,ACAD,neutral
13032.0,Benzinga's Volume Movers ,2013-04-11 11:29:00-04:00,ACAD,neutral
13033.0,"Piper Jaffray Upgrades ACADIA Pharmaceuticals Inc. to Overweight, Raises PT to $19.00",2013-04-11 11:20:00-04:00,ACAD,negative
13034.0,"Mid-Morning Market Update: Markets Continue to March Upwards, PC Makers Get Blasted",2013-04-11 10:38:00-04:00,ACAD,neutral
13035.0,Morning Market Movers ,2013-04-11 10:10:00-04:00,ACAD,neutral
13036.0,ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA ,2013-04-11 07:22:00-04:00,ACAD,neutral
13037.0,"McNicoll Lewis Vlak Maintains Buy on ACADIA Pharmaceuticals Inc., Raises PT to $12.50",2013-03-25 15:53:00-04:00,ACAD,neutral
13038.0,"Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)",2013-03-23 11:33:00-04:00,ACAD,positive
13039.0,Friday March 22th Watchlist,2013-03-22 08:42:00-04:00,ACAD,neutral
13040.0,"Market Wrap for Thursday, March 21: Stocks Give Back Wednesday's Gains",2013-03-21 16:08:00-04:00,ACAD,positive
13041.0,"Mid-Afternoon Market Update: Markets Remain in the Red, DryShips Posts Strong Rally",2013-03-21 14:58:00-04:00,ACAD,positive
13042.0,"Mid-Day Market Update: Herman Miller Surges On Upbeat Earnings, Scholastic Falls",2013-03-21 13:33:00-04:00,ACAD,neutral
13043.0,"Acadia Pharma Breaks Out Over $7 Resistance For New 52wk Highs After Phase III Results, Bullish MACD Cross On Daily",2013-03-21 10:52:00-04:00,ACAD,neutral
13044.0,"Mid-Morning Market Update: Markets Tumble, Oracle Posts Downbeat Results",2013-03-21 10:41:00-04:00,ACAD,neutral
13045.0,"ACADIA Presents Robust Phase III Results on Parkinson's Disease Psychosis Study with Pimavanserin, Shares Up 5% Pre-Market ",2013-03-21 07:53:00-04:00,ACAD,positive
13046.0,Wednesday March 20th Watchlist,2013-03-20 08:36:00-04:00,ACAD,neutral
13047.0,Benzinga's Top Initiations,2013-03-19 07:58:00-04:00,ACAD,positive
13048.0,UPDATE: Jefferies Initiates ACADIA Pharmaceuticals at Buy on Pimavanserin Optimism,2013-03-19 07:26:00-04:00,ACAD,positive
13049.0,"Jefferies Initiates Coverage on ACADIA Pharmaceuticals Inc. at Buy, Announces $13.00 PT",2013-03-19 06:20:00-04:00,ACAD,neutral
13050.0,ACADIA Pharmaceuticals Inc. Reports Q4 EPS of $(0.11) vs $(0.09) Est; Revenue of $380.0K vs $470.0K Est,2013-03-12 16:03:00-04:00,ACAD,neutral
13051.0,"Benzinga Market Primer: Tuesday, March 12",2013-03-12 06:49:00-04:00,ACAD,neutral
13052.0,"Earnings Scheduled For March 12, 2013",2013-03-12 04:41:00-04:00,ACAD,neutral
13053.0,"Option Alert: Acadia Pharmaceuticals January 2015 7.5/12 Call Spread; 20,000 Contracts @$1.40; Currently $6.27",2013-03-01 12:21:00-05:00,ACAD,positive
13054.0,Cowen & Company Initiates Coverage on ACADIA Pharmaceuticals Inc. at Outperform,2013-01-28 07:40:00-05:00,ACAD,neutral
13055.0,Acadia Pharma Registers 19.5M Share Shelf for Holder,2012-12-21 16:14:00-05:00,ACAD,positive
13056.0,Acadia Pharma Announces $86M Equity Financing,2012-12-12 09:05:00-05:00,ACAD,neutral
13057.0,Benzinga's Top Pre-Market Losers,2012-11-28 08:16:00-05:00,ACAD,negative
13058.0,Acadia Pharma Rockets Higher on Study Results,2012-11-27 16:44:00-05:00,ACAD,neutral
13059.0,"Option Alert: Acadia Pharmaceuticals December 5 Put; Block Trade 2X 3,125 Contracts @$0.40/$0.45, Currently $5.08",2012-11-27 15:24:00-05:00,ACAD,negative
13060.0,Needham Upgrades Acadia Pharmaceuticals from Hold to Buy,2012-11-27 11:37:00-05:00,ACAD,neutral
13061.0,"Top Narrow Based Indexes For November 27, 2012",2012-11-27 10:38:00-05:00,ACAD,positive
13062.0,Stocks Hitting 52-Week Highs,2012-11-27 10:06:00-05:00,ACAD,neutral
13063.0,Morning Market Movers,2012-11-27 09:49:00-05:00,ACAD,neutral
13064.0,Benzinga's Top Pre-Market Gainers,2012-11-27 08:13:00-05:00,ACAD,positive
13065.0,Acadia Shares Resume Up 140+%,2012-11-27 07:56:00-05:00,ACAD,positive
13066.0,ACADIA Pharmaceuticals Resumes Trading,2012-11-27 07:55:00-05:00,ACAD,neutral
13067.0,PREVIEW: ACADIA Pharmaceuticals to Resume Trading at 7:55 AM ET,2012-11-27 07:38:00-05:00,ACAD,neutral
13068.0,ACADIA's Pimavanserin Meets Primary and Key Secondary Endpoints in Pivotal Phase III Parkinson's Disease Psychosis Trial ,2012-11-27 07:27:00-05:00,ACAD,neutral
13069.0,Acadia Pimavanserin Phase 3 Results to be Announced Tuesday Morning -Adam F Tweet,2012-11-26 16:21:00-05:00,ACAD,neutral
13070.0,Acadia Pharmaceuticals Reports Q3 EPS $-0.04 vs $-0.09 Est; Revenues $3.5M vs $1.90M Est,2012-11-05 16:14:00-05:00,ACAD,neutral
13071.0,Stocks Hitting 52-Week Highs,2012-09-19 10:23:00-04:00,ACAD,neutral
13072.0,Benzinga's Top Pre-Market Gainers,2012-09-17 08:14:00-04:00,ACAD,positive
13073.0,Acadia Pharmaceuticals Spikes to High on Positive Seeking Alpha Post,2012-09-10 13:06:00-04:00,ACAD,positive
13074.0,Acadia Pharma Announces Completion of Enrollment in Phase III Pimavanserin Trial,2012-09-05 08:32:00-04:00,ACAD,neutral
13075.0,Acadia Pharmaceuticals Reports Q2 EPS $-0.10 vs $-0.12 Est; Revenues $599K vs $490.00K Est,2012-08-08 17:18:00-04:00,ACAD,neutral
13076.0,Acadia Pharmaceuticals Spikes Higher on Patent Publication,2012-07-24 10:18:00-04:00,ACAD,neutral
13077.0,"From Earlier, ACADIA Pharmaceuticals Reports Promising Effects of Pimavanserin in Preclinical Model of Alzheimer's Disease Psychosis   ",2012-07-09 09:21:00-04:00,ACAD,positive
13078.0,SunTrust Initiates Acadia Pharmaceuticals at Buy,2012-06-15 09:54:00-04:00,ACAD,neutral
13079.0,UPDATE: Ladenburg Thalmann Initiates Coverage on Acadia Pharmaceuticals,2012-04-30 09:17:00-04:00,ACAD,neutral
13080.0,Ladenburg Thalmann Initiates Coverage on Acadia Pharmaceuticals at Buy,2012-04-30 08:09:00-04:00,ACAD,neutral
13081.0,ACADIA Pharmaceuticals Awarded New Grant from The Michael J. Fox Foundation for Development of Nurr1-RXR Selective Agonists to Treat Parkinson's Disease   ,2012-03-27 09:03:00-04:00,ACAD,positive
13082.0,"Benzinga's Microcap Movers for Tuesday March 13, 2012",2012-03-14 07:46:00-04:00,ACAD,neutral
13083.0,Earnings Scheduled For March 6,2012-03-06 03:58:00-05:00,ACAD,neutral
13084.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2012-03-05 09:02:00-05:00,ACAD,neutral
13085.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2012-03-05 09:00:00-05:00,ACAD,neutral
13086.0,ACADIA Pharmaceuticals Advances AM-831 to Phase I Clinical Development in Collaboration with Meiji Seika Pharma; FDA Accepts Investigational New Drug Application,2011-11-07 08:04:00-05:00,ACAD,positive
13087.0,ACADIA Pharmaceuticals Spikes Higher,2011-08-29 10:03:00-04:00,ACAD,neutral
13088.0,"Earnings Scheduled For May 10 (DF, MCP, DIS, ACMR, MBI, MDR, WEN, ACAD, BLD, LIWA, AHCI, FRM, BKH, TAST, RDNT)",2011-05-10 02:13:00-04:00,ACAD,neutral
13089.0,"Top Percentage Gainers and Losers as of 2pm 5/04/11 (VSEA, ZSTN, GMCR, SGI, AMAT, WOLF, ACLS, MGM, VCLK, KNDI, SONS, ACAD, SWSH, CENX, QSFT, DVR, OPEN)",2011-05-04 14:01:00-04:00,ACAD,negative
13090.0,"Dream Stocks: April's Strongest Performers (SIFY, AMRN, REDF, KUTV, ACAD)",2011-04-29 11:06:00-04:00,ACAD,positive
13091.0,"Top Percentage Gainers and Losers as of 10am 4/26/11 (ECYT, USAT, REDF, ACAD, UCTT, GFRE, WIBC, LXK, VDSI, UIS)",2011-04-26 10:01:00-04:00,ACAD,negative
13092.0,"CEOWORLD Top 15 Stocks Picks Below $10- RMTR, APP, ACAD, HRZ, AIB, HNSN, QPSA, JRJC, TASR, RPRX, ONTY, LOOK, CT, SHZ, ESLR",2011-04-26 08:30:00-04:00,ACAD,positive
13093.0,"Top Trade Ideas for Thursday, April 21",2011-04-21 06:27:00-04:00,ACAD,positive
13094.0,Stocks to watch on Tuesday April 18,2011-04-18 17:58:00-04:00,ACAD,neutral
13095.0,"Top Trade Ideas for Tuesday, April 12",2011-04-11 16:52:00-04:00,ACAD,positive
13096.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2011-04-01 09:04:00-04:00,ACAD,neutral
13097.0,"Earnings Scheduled For March 10 (NSM, PLL, KIRK, ARO, BKE, MTN, ACAD, JMBA, ZUMZ, AAON, SWHC, AVII, LCUT, RAVN)",2011-03-10 02:51:00-05:00,ACAD,neutral
13098.0,Acadia To Offer Common Stock (ACAD),2011-01-14 16:12:00-05:00,ACAD,neutral
13099.0,"Morning Market Movers (GENE, ACAD, PSTI, PLA)",2011-01-10 10:09:00-05:00,ACAD,neutral
13100.0,5 Pharma Stocks Trading for Under $2,2010-12-16 12:18:00-05:00,ACAD,neutral
13101.0,ACADIA Pharmaceuticals Reports Third Quarter 2010 Financial Results: Loss of $0.11 Per Share,2010-11-09 16:08:00-05:00,ACAD,neutral
13102.0,Acadia Gets Pimavanserin Back - Analyst Blog,2010-10-28 13:03:00-04:00,ACAD,neutral
13103.0,"Small Caps Flying High (ACAD, TAMB, UCBH, ICTG)",2009-10-06 17:17:00-04:00,ACAD,neutral
13104.0,Acadia Pharmaceuticals (ACAD) down 65% today after failed study,2009-09-01 16:30:00-04:00,ACAD,negative
13105.0,Citigroup Downgrades Acadia Pharmaceuticals to Sell from Hold,2009-09-01 09:07:00-04:00,ACAD,neutral
13106.0,"Market Pulse Announces Its Hot Stock Alerts for Monday, July 27, 2009: CSEV, ACAD, CHINA, BRCM",2009-07-27 09:32:00-04:00,ACAD,neutral
